- Home
- ALKS vs NXE Comparison
ALKS vs NXE Comparison
Compare ALKS & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALKS
- NXE
- Stock Information
- Founded
- ALKS 1987
- NXE 2011
- Country
- ALKS Ireland
- NXE Canada
- Employees
- ALKS N/A
- NXE N/A
- Industry
- ALKS Biotechnology: Pharmaceutical Preparations
- NXE
- Sector
- ALKS Health Care
- NXE
- Exchange
- ALKS Nasdaq
- NXE Nasdaq
- Market Cap
- ALKS 4.9B
- NXE 5.0B
- IPO Year
- ALKS 1991
- NXE N/A
- Fundamental
- Price
- ALKS $30.82
- NXE $8.83
- Analyst Decision
- ALKS Strong Buy
- NXE
- Analyst Count
- ALKS 14
- NXE 0
- Target Price
- ALKS $41.43
- NXE N/A
- AVG Volume (30 Days)
- ALKS 1.9M
- NXE 9.5M
- Earning Date
- ALKS 10-23-2025
- NXE 11-07-2025
- Dividend Yield
- ALKS N/A
- NXE N/A
- EPS Growth
- ALKS 21.99
- NXE N/A
- EPS
- ALKS 2.08
- NXE N/A
- Revenue
- ALKS $1,505,296,000.00
- NXE N/A
- Revenue This Year
- ALKS N/A
- NXE N/A
- Revenue Next Year
- ALKS $1.59
- NXE N/A
- P/E Ratio
- ALKS $14.89
- NXE N/A
- Revenue Growth
- ALKS N/A
- NXE N/A
- 52 Week Low
- ALKS $25.17
- NXE $3.91
- 52 Week High
- ALKS $36.45
- NXE $9.43
- Technical
- Relative Strength Index (RSI)
- ALKS 62.83
- NXE 57.51
- Support Level
- ALKS $26.99
- NXE $8.57
- Resistance Level
- ALKS $31.68
- NXE $9.18
- Average True Range (ATR)
- ALKS 0.80
- NXE 0.45
- MACD
- ALKS 0.36
- NXE -0.05
- Stochastic Oscillator
- ALKS 81.88
- NXE 52.21
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
About NXE Nexgen Energy Ltd.
NexGen Energy Ltd is an exploration and development entity engaged in acquiring, evaluating, and developing uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin.